Alexion Pharmaceuticals, Inc.

Q3 2023 13F Holders

Symbol
ALXN
CUSIP
015351109
Type
Equity
Class
COM
Num filings
1
Total reported value, excl. options
$10.4 k
Manager Report Date Value ($000) Shares Option Type